Amgen(US:AMGN) Prnewswire·2026-01-28 21:01Core Viewpoint - Amgen will report its fourth quarter and full year 2025 financial results on February 3, 2026, followed by a conference call with senior management [1]. Group 1: Financial Results Announcement - The financial results will be announced after the close of U.S. financial markets on February 3, 2026 [1]. - A conference call will take place at 4:30 p.m. ET, featuring Robert A. Bradway, chairman and CEO, along with other senior management members [1]. Group 2: Conference Call Details - The conference call will be broadcast live over the internet, accessible to media, investors, and the general public [2]. - The webcast will be archived and available for replay for at least 90 days post-event [3]. Group 3: Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines for serious diseases [4]. - The company has a strong focus on utilizing technology and human genetic data to advance its pipeline of medicines targeting cancer, heart disease, inflammatory conditions, rare diseases, and obesity-related conditions [5]. Group 4: Industry Position - Amgen has been recognized for its innovation and workplace culture, receiving honors from Fast Company and Forbes [6]. - The company is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its status as one of the largest and most innovative non-financial companies [6].